During this appointment, youll have the opportunity to go over your health goals, current medications, and any existing medical conditions
Phase 3 Trial of Semaglutide in Metabolic DysfunctionAssociated Steatohepatitis, New England Journal of Medicine Consistent with previous trials, the semaglutide group also lost more body weight and had significant improvements in blood pressure, blood glucose, lipids, and inflammation compared to the placebo group
It activates melanocortin receptors, which are proteins in the brain and body that play a role in sexual function
But the trial-level evidence for safety and efficacy is limited
Your doctor will evaluate your medical history, current medications, and goals to recommend the best fit